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Background: There has been renewed interest in biopharmaceuticals based on plasmid DNA (pDNA) in recent
years due to the approval of several veterinary DNA vaccines, on-going clinical trials of human pDNA-based
therapies, and significant advances in adjuvants and delivery vehicles that have helped overcome earlier efficacy
deficits. With this interest comes the need for high-yield, cost-effective manufacturing processes. To this end, vector
engineering is one promising strategy to improve plasmid production.
Results: In this work, we have constructed a new DNA vaccine vector, pDMB02-GFP, containing the runaway R1
origin of replication. The runaway replication phenotype should result in plasmid copy number amplification after a
temperature shift from 30°C to 42°C. However, using Escherichia coli DH5α as a host, we observed that the highest
yields of pDMB02-GFP were achieved during constant-temperature culture at 30°C, with a maximum yield of
approximately 19 mg pDNA/g DCW being observed. By measuring mRNA and protein levels of the R1 replication
initiator protein, RepA, we determined that RepA may be limiting pDMB02-GFP yield at 42°C. A mutant plasmid,
pDMB-ATG, was constructed by changing the repA start codon from the sub-optimal GTG to ATG. In cultures of
DH5α[pDMB-ATG], temperature-induced plasmid amplification was more dramatic than that observed with
pDMB02-GFP, and RepA protein was detectable for several hours longer than in cultures of pDMB02-GFP at 42°C.
Conclusions: Overall, we have demonstrated that R1-based plasmids can produce high yields of high-quality pDNA
without the need for a temperature shift, and have laid the groundwork for further investigation of this class of
vectors in the context of plasmid DNA production.
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Gene therapies and DNA vaccines have gained attention
in recent years as potential treatments for a range of
acquired and infectious diseases. In particular, therapies
that use plasmid DNA (pDNA) as a vector are attractive
because they have a good safety profile and are relatively
easy to manufacture using Escherichia coli as a host.
Interest in the field has also been stimulated by the ap-
proval of several veterinary gene-based therapeutics and
on-going clinical trials of plasmid-based human thera-
peutics [1]. In addition, a recent Phase 2 trial of an
adenoviral-vectored DNA vaccine yielded disappointing
results [2], fueling safety and efficacy concerns sur-
rounding adenoviral vaccines. Finally, recent advances in
delivery vehicles and adjuvants for use in concert with* Correspondence: kljp@mit.edu
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distribution, and reproduction in any mediumnaked plasmid DNA have helped increase the efficacy of
these therapies [3]. Gene delivery via electroporation has
especially reinvigorated the field; early studies suggest
that DNA delivered using electroporation devices may
elicit immune responses on par with more traditional
vaccines [4].
Currently, plasmid DNA is produced almost exclu-
sively using vectors containing the high-copy pUC repli-
con. pUC-based plasmids are derivatives of the ColE1
origin of replication that lack the RNA one modulator
(Rom) protein and contain a point mutation in the RNA
II sequence. These two mutations together give increas-
ingly higher copy numbers as the culture temperature is
increased from 30°C to 42°C [5]. Extensive process de-
velopment has resulted in the design of very high-yield,
fed-batch processes for the production of pUC vectors
[6]. However, with the exception of the pCOR family of
plasmids based on the R6K replicon [7,8], no otherentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,













Figure 1 Feature map of pDMB02-GFP. DNA vaccine vector
features: Kanamycin resistance marker (KanR), human
cytomegalovirus immediate-early promoter/enhancer (PCMV),
superfolding GFP gene (sGFP), bovine growth hormone
polyadenylation signal (BGH PolyA). R1 replicon features: Replication
initiation protein gene (repA), antisense RNA gene (copA), repressor
of PrepA gene (copB), origin of replication (R1 ori). The point
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Figure 2 Comparison of specific yields of different vectors.
Specific yields of pCP40 (parent plasmid), pVAX1-GFP (pUC-based
DNA vaccine vector), and pDMB02-GFP (R1-based DNA vaccine
vector) with and without a temperature shift from 30°C to 42°C are
shown. Times in the legend refer to hours after the temperature
shift, and error bars represent the standard deviation calculated from
duplicate flasks.
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production.
One promising alternative to currently-available plas-
mids are vectors based on the so-called runaway R1 ori-
gin of replication. There are numerous reports in the
early plasmid literature about these high-copy mutants
of the E. coli plasmid R1. Runaway replication plasmids
lose control of their copy number at high temperatures
(> 37°C), resulting in plasmid copy numbers as high as
2000 copies per chromosome [9]. These high copy num-
bers suggest that runaway replication plasmids would be
well-suited for plasmid DNA production. The mechan-
ism of R1 replication has been described extensively
elsewhere [10]. In short, two point mutations confer the
runaway replication phenotype: one that decreases tran-
scription of the antisense RNA repressor copA, and a
second that increases transcription of the replication ini-
tiator protein gene, repA, in a temperature-dependent
fashion [11]. Runaway R1-based plasmids have been
used successfully for temperature-induced recombinant
protein production [12-15], but they have yet to be
investigated in the context of plasmid DNA production
for therapeutic applications.
This work describes the construction and charact-
erization of a new DNA vaccine vector, pDMB02-GFP, con-
taining the runaway R1 origin of replication that is capable
of producing high plasmid DNA yields. The yield trends of
our new vector were compared to the yields of both the
replicon source plasmid and a pUC-based DNA vaccine
vector at the shake flask scale in rich medium. We also
monitored the mRNA and protein expression of the plas-
mid replication initiator, repA, to gain insight into the
observed trends.
Results and discussion
Characterization of plasmid yield
We constructed a new DNA vaccine vector, pDMB02-GFP,
containing the runaway R1 replicon as described in the
Methods section (Figure 1). The vector also carries the
kanamycin resistance gene as well as the sequences neces-
sary for expression of therapeutic genes in a eukaryotic
host. For this work, we have included GFP as a placeholder
for the therapeutic gene sequence. The specific yield of the
new vector was compared to that of both the parent vector
(pCP40) and a pUC-based DNA vaccine vector (pVAX1-
GFP) after a mid-exponential phase temperature shift from
30°C to 42°C in LB medium (Figure 2). The pUC-based
vector behaved as expected – the specific yield remained
low (less than 1 mg/g DCW) at 30°C, and increased to
about 4 mg/g DCW after temperature induction. Both of
the R1-based plasmids produced higher specific yields than
the pUC-based plasmid – a difference only partially
accounted for by the larger size of the R1 plasmids. Inter-
estingly, while temperature-induced amplification wasobserved for the R1 vectors at early time points (2 and 4
hours after the temperature shift), at later time points the
yield at 30°C was higher than or the same as that at 42°C.
It should be noted that the parent vector, pCP40, contains
the phage lambda major leftward promoter (pL) upstream
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contain the pL repressor protein, we did not observe the
plasmid instability alluded to by Remaut et al. [16]. The
completely de-repressed phage promoter may not affect
pCP40 stability because there is no recombinant protein
sequence immediately downstream of pL.
To further investigate the production capabilities of
pDMB02-GFP, the specific yield after a temperature shift
later in exponential phase (OD600 = 1) was compared to
the yields obtained after a mid-exponential phase shift
(Figure 3). Typically, the temperature-shifted cultures
reached a lower final optical density than the cultures
that remained at 30°C, likely due to heat stress (Figure 3,
A and B). A period of increased growth rate was
observed between 0 and 2 hours post shift – possibly
due to the culture transiently being at optimal growth
temperature for E. coli (37°C) – followed by growth ar-
rest. The timing of the temperature shift did not signifi-
cantly impact the yield of the 42°C cultures, but resulted
in higher yields at 30°C, likely due to the increased
elapsed culture time. At 30°C, the cultures were typically
in stationary phase at the later sampling times. It is pos-
sible that the high plasmid yields measured at these time









































Figure 3 Growth and plasmid yield of DH5α[pDMB02-GFP] as a funct
temperature shift at OD600 = 0.5 and (B) OD600 = 1.0. (C) Specific yield of p
1.0. Data are shown for cultures shifted to 42°C (●) and cultures that rema
and error bars represent the standard deviation calculated from triplicate flplasmid amplification [17] and/or amplification in re-
sponse to nutrient starvation [18]. The maximum yield
achieved in these experiments (Figure 3) is on par with
the maximum yield produced by pCP40 (Figure 2), con-
firming that pDMB02-GFP did not lose any production
capacity during the construction process.
There are several possible explanations for the
experiment-to-experiment variability observed in the
maximum yield of pDMB02-GFP. The use of a rich
medium (LB) may be partially responsible, as the exact
medium composition can vary from run-to-run. How-
ever, the mechanism of R1 replication is not designed for
tight control of plasmid copy number. Instead, the goal is
to prevent the copy number from dropping below one
per cell – a concern that is more relevant for the low-
copy, wild-type R1 plasmid [10]. This may result in
increased clone-to-clone variability when the plasmid
copy number is significantly higher than one, as observed
in the runaway mutants.
Impact of seed growth phase on yield
In all of the experiments described above, shake flask cul-
tures were inoculated directly from working seed banks.









































ion of temperature shift timing. (A) Growth curves after a
DMB02-GFP after a temperature shift at OD600 = 0.5 and (D) OD600 =
ined at 30°C (△). 0 hr on the x-axis is the time of the temperature shift,
asks.
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of resulting cultures when using runaway replication plas-
mids for recombinant protein production [14]. To test the
sensitivity of DH5α[pDMB02-GFP] to seed age, we inocu-
lated flasks using seeds in late exponential, early stationary,
and late stationary phase and measured the specific plasmid
yield after 24 hours at 30°C. The data show that the plas-
mid production capacity of DH5α[pDMB02-GFP] cultures
inoculated using late-stationary seeds is greatly reduced
compared to cultures inoculated using seeds earlier in their
respective growth phases (Figure 4). In addition, the reduc-
tion in culture productivity corresponds to an increase in
the plasmid content of the seed culture, suggesting that
high plasmid content in the seed negatively impacts the
productivity of resulting cultures. These results are consist-
ent with the findings of a previous report [14]. Remaut
et al. [16] also alluded to the fact that runaway R1 plasmids
can be unstable after prolonged growth, even at low tem-
peratures. Direct inoculation from the working seed bank
gave yields comparable to those obtained from late expo-
nential/early stationary seeds, so we continued to use this
as our standard protocol for maximum run-to-run
consistency.
Quantification of repA gene expression
We were surprised to observe that pCP40 and pDMB02-
GFP did not show the dramatic temperature-induced
amplification reported in the early literature characteriz-
ing the runaway R1 replicon [9,16]. In particular, we
expected greater copy number control before the
temperature shift; however, we are not the first group to


























































Figure 4 Specific yield of pDMB02-GFP as a function of
inoculum growth phase. Specific yield after 24 hours of culture at
30°C in shake flasks is shown (gray bars). The plasmid copy numbers
of the seed cultures at each growth phase are also shown (▪).
Specific yield error bars represent one standard deviation calculated
from duplicate flasks, and copy number error bars represent the 95%
confidence interval calculated from three replicate wells of the same
sample.suppressed at 30°C [14,19]. To further investigate the
temperature-dependent behavior of pDMB02-GFP we
pursued additional studies at the RNA and protein
levels.
In the R1 replicon, the repA gene codes for a protein
required for initiation of replication at the origin and is
transcribed from both the PrepA and PcopB promoters
(Figure 5). copA is an antisense RNA that binds to and
inhibits translation of repA mRNA, and CopB is a tetra-
meric repressor of PrepA. The two point mutations that
lead to the runaway replication phenotype reduce the ef-
ficiency of PcopA and cause a temperature-dependent in-
crease in transcription from PcopB [11]. The replication
initiation protein, RepA, is likely the limiting factor in
plasmid replication, owing to the fact that multiple cop-
ies of the protein are required for initiation of replication
[10]. In the results that follow, we chose to focus our
analysis exclusively on repA. Our experiments were all
in the high-copy-number regime (compared to wild-type
plasmid R1), and under these conditions, CopB is likely
present in sufficiently high amounts to completely re-
press PrepA such that all repA mRNA is transcribed from
PcopB [20]. Also, the antisense RNA control element,
copA, is small and unstable [21] and as such we were
unable to obtain reliable measurements of its expression.
The expression of repA was calculated relative to one
flask at t = 0 hr. As an internal standard, the same
amount of total RNA was used for all reverse transcript-
ase reactions in lieu of a housekeeping gene, since it is
unlikely that transcription of a chromosomal target
would remain unchanged under all temperature and
growth conditions tested. Relative expression measure-
ments of repA in cultures of pDMB02-GFP with and
without a temperature shift showed that repA transcrip-
tion increased by an order of magnitude after the
temperature shift (Table 1). However, the pDNA specific
yield did not increase in a similar manner, consistent
with the observations made in previous experiments.
The repA expression data suggest that the runaway R1
replicon is functioning as expected, in that there is clear
temperature-induced expression of repA mRNA. How-
ever, as the plasmid copy number increases, the total
amount of repA mRNA in the culture is also expected to
increase. To account for this, we normalized repA ex-
pression to plasmid copy number to obtain an estimate
of the relative repA expression level per plasmid (Table 1)
and found that temperature-induced expression of repA
was still evident.
Role of RepA protein expression levels
The repA mRNA expression data pointed to the possibil-
ity of a post-transcriptional limitation on plasmid yield
at 42°C. One option for relieving this limitation is to in-





Figure 5 Schematic of the R1 replicon. The schematic was adapted from Nordström [10].
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resulting in the plasmid pDMB-ATG. There is evidence
in the literature that genes with a GTG start codon are
typically translated several-fold less efficiently than genes
with an ATG start codon [22]. We chose a start codon
mutation instead of a promoter replacement to minimize
disruption of the other elements of the replicon. Also,
since RepA is primarily cis acting [23], supplying RepA
exogenously from either the chromosome or an add-
itional plasmid was not a viable strategy for increasing
RepA availability.
In a mid-exponential phase temperature shift experi-
ment, pDMB-ATG showed distinctly different plasmid
yield profiles compared to pDMB02-GFP (Table 2). The
specific yield at 30°C was lower than that typically observed
for pDMB02-GFP, and there was an approximately five-
fold increase in specific yield after temperature induction.
repA RNA expression also showed temperature-induced
amplification (Table 2); the fold difference between the
30°C and 42°C cultures containing pDMB-ATG was ap-
proximately the same order of magnitude as that observed
for pDMB02-GFP (Table 1). However, when repA expres-
sion was normalized to plasmid copy number, temperature-
induced transcription of repA was still evident but to aTable 1 Specific yield, plasmid copy number, and repA expres
a temperature shift
Temperature Time (hr)a Specific Yield (mg pDNA/g DCW) Plasmid
30°C 0 NDb
2 1.5 ± 0.1
4 4.4 ± 0.2
8 7.0 ± 0.3
42°C 2 2.2 ± 0.0
4 4.2 ± 0.1
8 5.1 ± 0.6
Error bars represent the standard deviation of duplicate samples.
aTime after temperature shift.
bNot detected (below detection limit of HPLC assay).
cNormalized to repA expression at t = 0 in flask replicate 1.
drepA expression multiplied by a factor of (t = 0 plasmid copy number)/(plasmid co
plasmid.lesser degree; the mechanism responsible for this observa-
tion is unclear.
To qualitatively evaluate the expression of RepA protein
in cultures of DH5α[pDMB02-GFP] and DH5α[pDMB-
ATG] we used a Western blot to detect RepA using poly-
clonal antiserum obtained from rabbits [24]. For
pDMB02-GFP, a band corresponding to RepA (33 kDa)
was visible on the blot after 2 hr at 42°C and after 8 hr at
30°C, with the intensity of the RepA band being higher in
the 30°C lysate (Figure 6: Lanes 6 and 7). This suggests
that temperature-induced expression of RepA from
pDMB02-GFP was occurring two hours post-shift, but by
8 hours, protein was either no longer being translated or
was degraded, possibly by heat-shock-induced proteases
[25]. A higher molecular weight band is visible in all
lanes, but since this band is also present in the negative
control lanes (Figure 6: Lanes 1 and 3), it is most likely
due to cross-reaction with either the primary or second-
ary antibody rather than expression of RepA. As with spe-
cific plasmid yield, the trends in RepA expression were
also different for pDMB-ATG. A RepA band is visible in
the lanes corresponding to the 42°C samples at both 2
and 8 hours post-shift, and in the lane containing the
30°C sample at 8 hours post-shift (Figure 6: Lanes 11 – 13).sion in cultures of DH5α[pDMB02-GFP] with and without
copies/chromosome repA expressionc repA expression/plasmidd
42 ± 2 1.07 ± 0.10 1.07 ± 0.16
90 ± 9 0.69 ± 0.02 0.32 ± 0.05
144 ± 3 0.77 ± 0.25 0.22 ± 0.08
212 ± 72 1.40 ± 1.74 0.27 ± 0.36
153 ± 3 12.50 ± 2.55 3.40 ± 0.78
105 ± 39 28.15 ± 1.48 11.21 ± 4.33
177 ± 29 24.60 ± 0.14 5.78 ± 1.12
py number of sample) to give an estimate of normalized repA expression per
Table 2 Specific yield, plasmid copy number, and repA expression from cultures of DH5α[pDMB-ATG] with and without
a temperature shift
Temperature Time (hr)a Specific yield
(mg pDNA/g DCW)
Plasmid copies/chromosome repA expressionc repA expression/plasmidd
30°C 0 NDb 13 ± 3 0.09 ± 0.01 0.30 ± 0.09
2 0.2 ± 0.1 20 ± 4 0.06 ± 0.00 0.13 ± 0.03
4 1.0 ± 0.0 54 ± 1 0.20 ± 0.02 0.15 ± 0.02
8 2.3 ± 0.3 96 ± 27 0.32 ± 0.02 0.14 ± 0.04
42°C 2 1.9 ± 0.1 243 ± 32 1.00 ± 0.08 0.17 ± 0.03
4 5.1 ± 1.9 407 ± 210 15.20 ± 1.13 1.56 ± 0.83
8 11.4 ± 1.7 476 ± 176 9.85 ± 0.64 0.86 ± 0.34
Error bars represent the standard deviation of duplicate samples.
aTime after temperature shift.
bNot detected (below detection limit of HPLC assay).
cNormalized to repA expression from pDMB02-GFP at t = 0 in flask replicate 1 (Table 1).
drepA expression multiplied by a factor of (t = 0 pDMB02-GFP copy number)/(plasmid copy number of sample) to give an estimate of relative repA expression per
plasmid.
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It is clear that the kinetics of RepA expression are differ-
ent for pDMB-ATG, and that RepA expression persists
longer after the temperature shift when compared to ex-
pression from pDMB02-GFP.
Taken with the RNA expression data, the protein ex-
pression data for pDMB02-GFP suggest RepA protein
levels may be limiting replication at 42°C. While we can-
not deconvolute whether more RepA expression is leading
to higher copy number or vice versa, it is clear that RepA
protein is depleted after 8 hours at 42°C for the wild-type
plasmid, and that the start codon mutation increases
RepA protein levels at this time point. Despite this limita-
tion, we have shown that high yields of pDMB02-GFP can1 2 3 4 5 6 7 8
Controls pDMB02-GFP
   (-)  (+)  (-) 0h   2h  2h 8h 8h
30°C 42°C 30°C 42
Figure 6 Western blot for RepA. The RepA band is indicated by the arro
marker (Lane 14), all lanes contained crude lysates from the cultures indica
[pETDuet-repA], Lane 3: DH5α (no plasmid), Lane 4: DH5α[pDMB02-GFP] t =
DH5α[pDMB02-GFP] t = 2 hr 42°C, Lane 7: DH5α[pDMB02-GFP] t = 8 hr 30°
t = 0 hr, Lane 10: DH5α[pDMB-ATG] t = 2 hr 30°C, Lane 11: DH5α[pDMB-AT
DH5α[pDMB-ATG] t = 8 hr 42°C, Lane 14: Protein marker. All lanes containe
protein. Times refer to hours after the temperature shift. Results are shown
observed for the second replicate samples as well.be produced during constant-temperature growth at 30°C
without a temperature shift. This is particularly advanta-
geous for production-scale runs, as it reduces the com-
plexity of the process and allows the culture to achieve a
higher final cell density and higher volumetric yields. In
addition, the mutant plasmid pDMB-ATG seems to per-
form better at 42°C, making it the more attractive vector if
a temperature-shift process is desired.
Plasmid quality
For biopharmaceutical applications, it is important to as-
sess the quality of the plasmid DNA produced in
addition to the yield. While there is some debate over




0h   2h   2h 8h 8h 
30°C 42°C 30°C 42°C 
w to the right of the image. Except for the lane containing the protein
ted. Lane 1: BL21 Star (DE3) [pETDuet-1], Lane 2: BL21 Star (DE3)
0 hr, Lane 5: DH5α[pDMB02-GFP] t = 2 hr 30°C, Lane 6:
C, Lane 8: DH5α[pDMB02-GFP] t = 8 hr 42°C, Lane 9: DH5α[pDMB-ATG]
G] t = 2 hr 42°C, Lane 12: DH5α[pDMB-ATG] t = 8 hr 30°C, Lane 13:
d 2 μg total protein, except for Lane 2, which contained 0.4 μg total
for a single set of flasks, but the same trends in RepA expression were
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FDA currently recommends that plasmid DNA biophar-
maceuticals contain predominantly the supercoiled iso-
form [26]. Gel electrophoresis analysis of samples of
pDMB02-GFP and pDMB-ATG collected from cultures
with and without a temperature shift show a high per-
centage of supercoiled DNA (Figure 7). Also, the trends
in plasmid quantity are consistent with the specific yield
measured for these samples (Table 1 and Table 2).
These data show that neither the elevated temperature
nor the start codon mutation had a negative impact on
plasmid quality. Thus, pDMB02-GFP and pDMB-ATG
are capable of producing not only high yields of plasmid
DNA, but high quality product as well.
Conclusions
In this work, we have described construction of a new
DNA vaccine vector, pDMB02-GFP, containing the run-
away R1 origin of replication. Our new vector produced
high yields of high-quality plasmid DNA during
constant-temperature culture at 30°C. The runaway R1
replicon has been reported to result in a temperature-
dependent loss of copy number control, with higher copy
numbers at higher temperatures. However, while we
observed some temperature-induced amplification of
pDMB02-GFP shortly after a temperature shift, at longer
times, the yield at 30°C was often higher than that at 42°C.













Figure 7 Plasmid DNA quality assessment. Agarose gel
electrophoresis of pDMB02-GFP and pDMB-ATG produced in DH5α
with and without a mid-exponential phase temperature shift from 30°C
to 42°C. Lane 1: DNA ladder with DNA size in kilobases (kb) indicated
to the left of the image, Lane 2: pDMB02-GFP t = 2 hr 30°C, Lane 3:
pDMB02-GFP t = 2 hr 42°C, Lane 4: pDMB02-GFP t = 4 hr 30°C, Lane 5:
pDMB02-GFP t = 4 hr 42°C, Lane 6: pDMB02-GFP t = 8 hr 30°C, Lane 7:
pDMB02-GFP t = 8 hr 42°C, Lane 8: pDMB-ATG t = 2 hr 30°C, Lane 9:
pDMB-ATG t = 2 hr 42°C, Lane 10: pDMB-ATG t = 4 hr 30°C, Lane 11:
pDMB-ATG t = 4 hr 42°C, Lane 12: pDMB-ATG t = 8 hr 30°C, Lane 13:
pDMB-ATG t = 8 hr 42°C, Lane 14: DNA ladder. Times refer to hours
after the temperature shift.demonstrated that RepA protein availability may be limit-
ing pDMB02-GFP yield at 42°C. To increase RepA protein
levels, we constructed a second vector, pDMB-ATG, in
which the start codon of repA was changed from the sub-
optimal GTG to ATG. RepA was detected in cultures of
DH5α[pDMB-ATG] up to 8 hours after a temperature
shift and was accompanied by enhanced temperature-
dependent plasmid amplification.
Overall, we have developed a new set of high-yielding
DNA vaccine vectors that are well suited to processes run
at low temperatures (pDMB02-GFP) as well as processes
that include a temperature shift (pDMB-ATG). Future
work to systematically vary the expression of RepA and to
determine the resulting effects on specific yield will guide
additional efforts to maximize plasmid production. Fur-
thermore, the mechanistic insight into the factors limiting
R1 replication gained in this work can serve as the basis
of scale-up studies to investigate R1-based DNA vaccine
vectors under industrially-relevant conditions.
Methods
E. coli strains and plasmids
E. coli strain DH5α [F- φ80lacZΔM15 Δ(lacZYA-argF)
U169 deoR recA1 endA1 hsdR17(rk
- , mk
+) phoA supE44
thi-1 gyrA96 relA1 λ-] and the plasmid pVAX1 (2999 bp)
were purchased from Invitrogen (Carlsbad, CA).
pVAX1-GFP (3642 bp) was constructed by cloning the
superfolding green fluorescent protein (sGFP) gene [27]
into the multi-cloning site of pVAX1. The sGFP gene
was obtained from pTrcsGFP, a gift from the Gregory
Stephanopoulos laboratory (Department of Chemical
Engineering, Massachusetts Institute of Technology,
Cambridge, MA, USA). pCP40 (5029 bp) was con-
structed by Remaut et al. [16] and was obtained from
the Belgian Coordinated Collections of Microorganisms
BCCM/LMBP plasmid collection (accession number
LMBP 951).
To construct pDMB02-GFP, a 1938-bp fragment of
pVAX1 containing the human cytomegalovirus (CMV)
immediate-early promoter/enhancer, bovine growth hor-
mone (BGH) polyadenylation signal, and kanamycin resist-
ance gene was PCR-amplified using primers containing
AvrII and SbfI restriction sites. A 3073-bp fragment of
pCP40 containing the R1 origin of replication along with
the repA, copA, and copB gene sequences was also PCR-
amplified with the same restriction sites. The pVAX1 and
pCP40 fragments were ligated to construct the plasmid
pDMB02. The sGFP gene was cloned into the NheI and
XhoI restriction sites downstream of the CMV promoter/
enhancer. A Kozak sequence was also inserted at the start
of the sGFP gene by adding the sequence ACC before the
start codon and a valine codon (GTG) following the start
codon. The Kozak sequence should help facilitate sGFP
gene expression in mammalian cells [28]. The resulting
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rect construction was confirmed by restriction digests and
sequencing.
The start codon of repA in pDMB02-GFP was mutated
from GTG to ATG using site-directed mutagenesis
resulting in the plasmid pDMB-ATG. Primers containing
the mutation were used to amplify pDMB02-GFP using
20 cycles of PCR with Phusion high-fidelity DNA poly-
merase (New England Biolabs; Ipswich, MA). The pri-
mers were purified using a reverse phase cartridge by
the vendor (Sigma-Aldrich; St. Louis, MO) and their





After PCR, the template plasmid was digested using
DpnI, and after clean-up the reaction was used to trans-
form ElectroMAX DH10B cells (Invitrogen). Positive
transformants were selected on LB/agar plates contain-
ing 50 μg/mL kanamycin, and the presence of the start
codon mutation was verified by sequencing.Preparation of working seed banks
Frozen working seed banks of DH5α[pDMB02-GFP] and
DH5α[pDMB-ATG] were prepared by transforming sub-
cloning-efficiency, chemically-competent DH5α (Invitro-
gen) with purified plasmid. Positive transformants were
selected on LB/agar plates containing 25 μg/mL kana-
mycin. After overnight incubation at 30°C, a single col-
ony was used to inoculate 3 mL of LB medium
containing 25 μg/mL kanamycin. The culture was incu-
bated overnight at 30°C. The next day, 500 μL of over-
night culture was used to inoculate 50 mL of LB
medium containing 25 μg/mL kanamycin in a 250-mL
shake flask. The culture was incubated at 30°C until
mid-exponential phase (OD600 approximately equal to
0.5), at which time 900 μL of culture was added to 900
μL of cold 30% (v/v) glycerol in a cryogenic vial and im-
mediately stored at −80°C. Working seed bank vials were
discarded after two freeze-thaw cycles.Culture conditions
Difco LB Broth, Miller (BD; Franklin Lakes, NJ) was
used for shake flask cultures and contained 10 g/L tryp-
tone, 5 g/L yeast extract, and 10 g/L NaCl. Cell density
was monitored using OD600 measurements on a DU800
spectrophotometer (Beckman Coulter; Indianapolis, IN).
All cultures were mixed and aerated by agitation at 250
rpm unless otherwise specified.Temperature shift experiments
Temperature-induced plasmid amplification was stud-
ied using temperature shift experiments as follows: 100
to 110 mL of LB medium containing 25 μg/mL kana-
mycin (or 100 µg/mL ampicillin for pCP40) was inocu-
lated to an initial OD600 = 0.00025 using working seed
bank. The very low initial OD600 was chosen to avoid
glycerol carry-over from the working seed bank vial.
The cultures were incubated in 500-mL baffled shake
flasks at 30°C until the desired growth phase was
achieved (typically OD600 = 0.5 – 1.0) at which point
half of the culture volume was transferred to a 250-
mL shake flask and incubated at 42°C. The remaining
culture was transferred to a 250-mL shake flask and
incubated at 30°C.
Seed growth phase study
5 mL LB containing 25 μg/mL kanamycin was inocu-
lated with 20 μL of DH5α[pDMB02-GFP] working seed
bank and incubated at 30°C. Aliquots of the culture were
collected in late exponential (OD600 = 1.1), early station-
ary (OD600 = 2.3), and late stationary (OD600 = 2.8)
growth phases and used to inoculate 50 mL LB contain-
ing 25 μg/mL kanamycin to an initial OD600 = 0.01. The
resulting cultures were incubated at 30°C for at least 24
hours. Samples were taken periodically to measure cell
growth and plasmid production.
Measurement of plasmid copy number
Plasmid copy number was determined from 100 μL of cul-
ture using the quantitative PCR (qPCR) method described
by Bower et al. [29] In short, SYBR Green was used to de-
tect amplification of plasmid-based and chromosomal
gene targets from total DNA samples diluted 5-fold (if ne-
cessary) to be within the linear range of the assay. The
ΔΔCT method [30] was used to calculate plasmid copy
number.
Measurement of plasmid DNA specific yield
Plasmid DNA was quantified from crude lysates pre-
pared from OD600 = 10 cell pellets using the method
described previously [29]. Briefly, crude lysates were run
on a Gen-Pak FAX anion-exchange column (Waters
Corporation; Milford, MA) and pDNA was eluted using
a NaCl gradient. Plasmid detected by absorbance at 260
nm was quantified using a standard curve of known
quantities of purified plasmid DNA. Specific yield could
then be calculated using the correlation that 1 OD600
unit = 0.4 g DCW/L culture.
Measurement of repA mRNA expression
repA mRNA expression was measured using a quan-
titative real-time PCR assay. RNA was purified from
OD600 = 1 pellets using the Illustra RNAspin Mini RNA
Bower and Prather Microbial Cell Factories 2012, 11:107 Page 9 of 10
http://www.microbialcellfactories.com/content/11/1/107Isolation Kit (GE Healthcare; Piscataway, NJ). 1 g/L lyso-
zyme was used for cell lysis in the first step of the proto-
col. Due to the high plasmid DNA content of the strains
used in this work, an additional DNase digestion was
required after the RNA purification step to remove con-
taminating DNA. 43 μL purified RNA was digested with
2 μL DNase I (New England Biolabs) in 5 μL of the
supplied reaction buffer for 10 min. at 37°C. RNA was
purified from the other reaction components using the
RNA Cleanup protocol from the RNeasy Mini Kit
(Qiagen; Valencia, CA). The RNA content of each sam-
ple was measured using a NanoPhotometer (Implen;
Westlake Village, CA), and 800 ng of RNA was con-
verted to cDNA using the QuantiTect Reverse Tran-
scription Kit (Qiagen). Control reactions containing
water instead of the reverse transcriptase enzyme were
included for each sample.
Quantitative PCR was performed on a 7300 Real-Time
PCR System (Applied Biosystems; Carlsbad, CA). The
desired reference sample was diluted 2- to 1000-fold to
prepare a standard curve. repA mRNA was detected using
gene-specific primers (forward primer: 5’-CAGAGCT
TAAGTCCCGTGGAAT-3’, reverse primer: 5’-TGA
CGTTCTCTGTTCGCATCA-3’) designed by Primer
Express 3.0 software (Applied Biosystems). Each 25-μL re-
action contained 1X Brilliant II SYBR Green QPCR High
ROX Master Mix (Agilent Technologies; Santa Clara,
CA), 200 nM each of the forward and reverse primers,
and the experimental sample diluted 100-fold. The ther-
mal cycling conditions were a 95°C hold for 10 min., fol-
lowed by 40 cycles of 95°C for 30 sec. and 60°C for 1 min.
Dissociation-curve analysis was also performed to check
for the presence of primer dimers or non-specific pro-
ducts. Results were analyzed using the Applied Biosystems
Sequence Detection Software (v. 1.3.1).
Immuno-detection of RepA protein
Removal of cross-reactive antibodies from RepA antiserum
Polyclonal RepA antiserum was a generous gift
from Prof. Rafael Giraldo (Centro de Investigaciones
Biológicas, Madrid, Spain) and was prepared as
described by Giraldo-Suárez et al. [24]. To reduce
background binding, the RepA antiserum was incu-
bated with plasmid-free DH5α lysate to precipitate
non-specific E. coli-reactive antibodies. A lysate of
plasmid-free DH5α was prepared from 50 mL of mid-
exponential phase culture grown in LB medium by
freeze-thaw and sonication in buffer containing 10 mM
Tris–HCl at pH 7.5, 140 mM NaCl, 1% Triton X-100,
1% BSA, 1% sodium deoxycholate, and 1 Complete Mini
Protease Inhibitor Cocktail tablet (Roche; Indianapolis,
IN) per 10 mL. The DH5α lysate was added to an ali-
quot of RepA antiserum in a 1:1 ratio and incubated at
room temperature for 5.5 hr with gentle rocking. Afterincubation, the antiserum was centrifuged for 20 min. at
20000 x g and 4°C. The supernatant was recovered and
stored in single-use aliquots at −80°C.
Cell lysis
Cell lysates were prepared by resuspending pellets pre-
pared from 4–5 mL of culture in 1 mL 10 mM Tris–
HCl at pH 8.0. The 1-mL suspension was added to
approximately 500 μL of 0.1 mm glass beads (Scientific
Industries; Bohemia, NY) in a 1.7-mL microcentrifuge
tube. The suspension and glass beads were vortexed at
maximum speed for 5 min. followed by centrifugation
for 20 min. at 14000 x g and 4°C. The supernatant was
recovered and stored at −30°C.
SDS-PAGE
Total protein content of the lysates was measured using
the modified Bradford assay described by Zor and Selinger
[31]. A 7.5-μl aliquot of each lysate containing 2 μg total
protein (balance water) was prepared. An equal volume of
Laemmli buffer containing 5% (v/v) β-mercaptoethanol
was added to each aliquot, and the samples were incu-
bated at 100°C for 5 min. Samples were loaded on a 10%
Mini-PROTEAN TGX Gel with 15 x 15-μL wells (Bio-
Rad; Hercules, CA) and run at 200 V for 30 min in tris/
glycine/SDS buffer.
Western blots
Protein separated by SDS-PAGE was transferred to a
nitrocellulose membrane (Pall Corporation; Pensacola,
FL) for 1 hr at 100 V using a Mini Trans-Blot Electro-
phoretic Transfer Cell (Bio-Rad) with transfer buffer
containing 25 mM Tris, 192 mM glycine, and 20% (v/v)
methanol at pH 8.3. After transfer, the membrane was
blocked with a 5% (w/v) bovine serum albumin solution
prepared in TBS (2.42 g/L Tris, 29.24 g/L NaCl, pH 7.5)
at room temperature for 2 hr. After two 10-min. washes
with TBST solution (TBS + 0.05% v/v Tween-20), the
membrane was incubated with a 1:1000 dilution of RepA
antiserum in TBS containing 10% glycerol for 2 hr at
room temperature. The membrane was washed three
times with TBST for 10 min. each, and was then incu-
bated with a 1:5000 dilution of goat anti-rabbit IgG-HRP
secondary antibody (Santa Cruz Biotechnology; Santa
Cruz, CA) in TBS for 1 hr. After two 10-minute washes
with TBST and one 10-minute wash with TBS, secondary
antibody binding was visualized using Western Blotting
Luminol Reagent (Santa Cruz Biotechnology) following
the manufacturer’s instructions.
Cloning and expression of repA
To verify that the band being detected on the Western
blots was indeed RepA, a positive control vector was
constructed by cloning the repA gene into the BamHI/
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MA), in-frame with an N-terminal 6X His tag. The
resulting plasmid, pETDuet-repA, was used to express
RepA-His in E. coli BL21 Star (DE3) (Invitrogen). 50-mL
LB cultures of BL21 Star (DE3) containing either
pETDuet-repA or pETDuet-1 and 100 μg/mL ampicillin
were grown at 30°C with 250 rpm shaking and induced
with 0.5 mM IPTG at an OD600 of approximately 0.5.
Six hours after induction, 20-mL aliquots of culture were
harvested by centrifugation. Lysates were prepared from
the pellets using disruption with 0.1 mm glass beads
(Scientific Industries) in buffer containing 7 M urea, 0.1
M NaH2PO4, and 0.01 M Tris–HCl at pH 8.0.
Plasmid quality assessment
Plasmid DNA purified from OD600 = 2 pellets using the
Zyppy Plasmid Miniprep Kit (Zymo Research Corporation;
Irvine, CA) was run on a 0.7% agarose gel at 90 V for 60
min. to separate the supercoiled, nicked (open-circle), and
linear isoforms. The separated DNA was visualized by
staining the gel with 0.5 μg/mL ethidium bromide.
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